BML Investment Partners, L.P. → ORAMED PHARMACEUTICALS INC. ORMP

Stake: — Shares: — Class: Common Stock par value $0.012 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

6 filings by this filer

5 other filings in the data moat

Short Interest · settle 2026-07-31

DTC 5.69

835,493 shares short · +9.2% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $73K

Point72 Asset Mgmt

Other 13D/G Filings on ORAMED PHARMACEUTICALS INC.

Filed	Form	Filer	Stake	Shares
2021-09-02	SC	KIDRON NADAV	—	—	view →

Other Filings by BML Investment Partners, L.P.

Filed	Form	Issuer	Stake	Shares
2025-03-05	SCHEDULE	Aadi Bioscience, Inc. WHWK	4.98%	2,435,000	view →
2025-02-24	SCHEDULE	Aadi Bioscience, Inc. WHWK	9.90%	2,435,000	view →
2025-02-04	SCHEDULE	Aadi Bioscience, Inc. WHWK	9.90%	2,435,000	view →
2024-01-11	SC	Forte Biosciences, Inc. FBRX	—	—	view →
2022-07-07	SC	Forte Biosciences, Inc. FBRX	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →